Open AccessAdjuvant therapy with heparin in patients with lung cancer without indication for anticoagulants: A systematic review of the literature with meta-analysis
Author(s) -
Yuman Yu,
Qun Lv,
Bin Zhang,
Fang Lan,
Yifan Dai
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.191627
Subject(s) - medicine , lung cancer , hazard ratio , meta analysis , heparin , relative risk , randomized controlled trial , placebo , cancer , confidence interval , oncology , surgery , pathology , alternative medicine
The effect of heparin in improving cancer survival has gained increasing attention over the past decades. Several clinical trials have evaluated the role of heparin on survival outcome and its safety profile in lung cancer patients. Thus, we performed a systematic review and meta-analysis from the results of randomized controlled trials (RCTs) to assess the efficacy and safety of heparin in patients with lung cancer without indication for anticoagulants.